Japan IP court upholds drug patent while citing insufficiency in prior art evidence
In a recent ruling, Japan’s Intellectual Property High Court upheld the validity of a patent for a drug to treat Parkinson's, dismissing the plaintiffs' claims of invalidity. While the court maintained...To view the full article, register now.
Already a subscriber? Click here to view full article